Dr. Fu is an experienced business leader in the vaccine space. Dr. Fu arrives at Codagenix after spending nearly 30 years at Merck & Co. where he led the company’s North America pharmaceutical and global vaccine commercial business development activities. During his nearly 30 years at Merck, Dr. Fu held positions of increasing responsibility, most recently serving as Corporate Finance Executive Director, Business Development and as a member of Merck’s U.S. Market and Global Vaccines leadership teams. In this capacity, Dr. Fu led business development strategy, negotiations and transactions across Merck’s global vaccines and North American pharmaceuticals. Prior to this, Dr. Fu held multiple senior level positions in Merck’s business development, marketing and sales, and research and development organizations. Dr. Fu holds a Ph.D. in Chemical Engineering/Biochemistry from Cornell University, an MBA with University honors from Carnegie Mellon University and a B.S. with honors in Chemical Engineering from the University of California, Berkeley.